Centessa Pharmaceuticals (CNTA) Non Operating Income: 2022-2025
Historic Non Operating Income for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Sep 2025 value amounting to -$1.8 million.
- Centessa Pharmaceuticals' Non Operating Income fell 149.40% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year decrease of 182.68%. This contributed to the annual value of -$1.7 million for FY2024, which is 68.92% up from last year.
- Per Centessa Pharmaceuticals' latest filing, its Non Operating Income stood at -$1.8 million for Q3 2025, which was down 150.39% from $3.6 million recorded in Q2 2025.
- Centessa Pharmaceuticals' 5-year Non Operating Income high stood at $5.4 million for Q2 2022, and its period low was -$4.0 million during Q4 2024.
- In the last 3 years, Centessa Pharmaceuticals' Non Operating Income had a median value of -$1.3 million in 2023 and averaged -$391,545.
- Its Non Operating Income has fluctuated over the past 5 years, first crashed by 1,154.29% in 2023, then spiked by 2,232.47% in 2025.
- Over the past 4 years, Centessa Pharmaceuticals' Non Operating Income (Quarterly) stood at -$70,000 in 2022, then tumbled by 1,154.29% to -$878,000 in 2023, then crashed by 351.94% to -$4.0 million in 2024, then crashed by 149.40% to -$1.8 million in 2025.
- Its last three reported values are -$1.8 million in Q3 2025, $3.6 million for Q2 2025, and $1.0 million during Q1 2025.